Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

29 Apr 2021 07:00

RNS Number : 9817W
Devro PLC
29 April 2021
 

Devro plc

 

Trading Update

 

Devro plc ("Devro" or the "Company"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 January 2021 to the current date ahead of its Annual General Meeting today.

Current trading

Q1 2021 edible collagen volumes increased 4.6% compared to the prior year driven by continued good underlying momentum and execution of our growth initiatives. Emerging markets were up 15% led by strong growth in China, South East Asia and Latin America. Mature markets were flat on the prior year, an improvement on the trends seen in 2020. Japan and North America both delivered strong growth but this was offset by lower demand in the UK & Ireland which had benefitted from elevated retail volumes in March 2020 as the pandemic took hold.

Financial position

The Group delivered strong cashflows during Q1, ending the quarter with comparable levels of leverage to 2020 year-end, including the dividend payment made in January 2021.

The Group repaid the US$25 million private placement due on the 19 April 2021 using a combination of available cash resources and RCF drawings. Post this repayment the Group maintains significant liquidity but with a lower average cost of borrowing.

The Group's remaining debt facilities consist of a committed £105 million Revolving Credit Facility (RCF), which expires in 2023, and US$75 million of private placements expiring April 2024 (US$50 million) and 2026 (US$25 million).

Outlook

We are encouraged by the good volume growth performance in Q1 and, whilst we expect this trend to continue we remain mindful of the uncertainties arising from the ongoing COVID-19 pandemic and likely foreign exchange headwinds. As a result, our expectations for 2021 remain unchanged.

ENDS 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Rohan Cummings

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain

Nick Hasell

Tel: 020 3727 1340

 

Dividend: In the Company's announcement on 2 March 2021 of its results for the year ended 31 December 2020, the Board proposed a final dividend of 6.3p per share (the "2020 Final Dividend") to be paid on 1 October 2021, to those shareholders on the register at 20 August 2021, subject to shareholder approval at the Annual General Meeting in April 2021. The Board has subsequently resolved to recommend the payment of the 2020 Final Dividend be brought forward from 1 October 2021 to 20 July 2021, to those shareholders on the register at 11 June 2021.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEFFWAEFSEDL
Date   Source Headline
13th Sep 20183:23 pmRNSHolding(s) in Company
3rd Sep 20184:44 pmRNSHolding(s) in Company
9th Aug 20181:48 pmRNSDirector/PDMR Shareholding
9th Aug 20181:45 pmRNSDirector/PDMR Shareholding
1st Aug 20184:55 pmRNSHolding(s) in Company
1st Aug 20187:00 amRNSHalf Year Results
9th Jul 20184:30 pmRNSHolding(s) in Company
4th Jul 20183:58 pmRNSHolding(s) in Company
4th Jun 20183:19 pmRNSHolding(s) in Company
16th May 20182:47 pmRNSHolding(s) in Company
15th May 20183:11 pmRNSDirector/PDMR Shareholding
14th May 20184:46 pmRNSDirector/PDMR Shareholding
8th May 20182:30 pmRNSHolding(s) in Company
4th May 201810:41 amRNSHolding(s) in Company
30th Apr 20183:28 pmRNSDirector/PDMR Shareholding
25th Apr 20184:49 pmRNSAGM - VOTING RESULTS
25th Apr 20187:00 amRNSTrading Update
19th Apr 20183:38 pmRNSHolding(s) in Company
10th Apr 201811:11 amRNSDirector/PDMR Shareholding
9th Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20187:06 amRNSDirector Declaration
29th Mar 20181:00 pmRNSAppointment of Chief Financial Officer
23rd Mar 20184:00 pmRNS2017 Annual Report and Notice of AGM
28th Feb 201811:28 amRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSDirectorate change confirmation
27th Feb 20187:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2017
7th Feb 20184:52 pmRNSHolding(s) in Company
12th Jan 20184:08 pmRNSHolding(s) in Company
5th Jan 20184:54 pmRNSHolding(s) in Company
19th Dec 20172:26 pmRNSHolding(s) in Company
19th Dec 20179:20 amRNSHolding(s) in Company
18th Dec 20174:33 pmRNSHolding(s) in Company
11th Dec 20173:02 pmRNSDirector/PDMR Shareholding
11th Dec 20177:00 amRNSDirectorate Change
9th Nov 20177:00 amRNSTrading Update
26th Oct 201712:20 pmRNSDirector/PDMR Shareholding
18th Aug 20174:18 pmRNSHolding(s) in Company
17th Aug 20175:03 pmRNSHolding(s) in Company
8th Aug 201710:35 amRNSHolding(s) in Company
2nd Aug 20174:54 pmRNSDirector/PDMR Shareholding
2nd Aug 20174:46 pmRNSDirector/PDMR Shareholding
2nd Aug 20174:45 pmRNSDirector/PDMR Shareholding
2nd Aug 20177:00 amRNSDevro plc Half Year Results 2017
23rd Jun 201710:03 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
30th May 201711:01 amRNSBlock Listing Six Monthly Return
16th May 20172:38 pmRNSHolding(s) in Company
26th Apr 20175:15 pmRNSResult of AGM
26th Apr 20177:00 amRNSTrading Update
20th Apr 20178:32 amRNSHolding(s) in Company
11th Apr 20174:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.